- HK$1.52bn
- HK$620.38m
- CNY768.90m
- 61
- 91
- 74
- 90
Annual balance sheet for PW Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,702 | 2,412 | 1,388 | 1,595 | 1,687 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 172 | 139 | 407 | 285 | 264 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,086 | 2,593 | 1,946 | 2,032 | 2,094 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 721 | 628 | 959 | 933 | 922 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 5,284 | 3,915 | 4,989 | 5,152 | 5,161 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 138 | 104 | 168 | 149 | 177 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 175 | 123 | 1,044 | 1,108 | 1,190 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 5,108 | 3,792 | 3,945 | 4,044 | 3,971 |
Total Liabilities & Shareholders' Equity | 5,284 | 3,915 | 4,989 | 5,152 | 5,161 |
Total Common Shares Outstanding |